跳至主要内容
临床试验/NCT04958798
NCT04958798已完成不适用

Culturally Centering Medications for Opioid Use Disorder With American Indian and Alaska

New York State Psychiatric Institute6 个研究点 分布在 1 个国家目标入组 2,059 人开始时间: 2021年12月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,059
试验地点
6
主要终点
# consumers with OUD initiated onto MOUD

研究概览

简要总结

This is a formative research study to test a culturally-centered, program-level implementation intervention to increase the use of medications for opioid use disorder in four healthcare and addiction specialty treatment sites serving American Indian and Alaska Native communities.

详细描述

This is a formative research study to test a culturally-centered, program-level implementation intervention to increase the use of medications for opioid use disorder (MOUD) in four healthcare and addiction specialty treatment sites serving American Indian and Alaska Native communities. The study design is a cluster randomized stepped wedge implementation trial with two steps, and two sites per step (N=4 sites). Study design and methods are informed by the Consolidated Framework for Implementation Research (CFIR) and the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, Maintenance). The primary outcome of the trial is the number of consumers with OUD initiated onto MOUD (i.e., buprenorphine, extended-release naltrexone, or methadone) in the 6 months after intervention delivery (compared to the 6 months before intervention delivery) - capturing implementation intervention Reach. The primary outcome will be measured at the end of the six-month implementation stage and compared to the pre-intervention observation phase (prior to delivery of the implementation intervention). Primary data collection will use de-identified data from the electronic medical records (EMR) at each site beginning with data from the six months prior to intervention delivery for Step 1 sites and 12 months prior for Step 2 sites. For Step 1 sites, some secondary outcomes will also be assessed during the sustainment stage (the six months following implementation) but this will be exploratory. As part of the study, consumers with OUD will be asked to participate in additional assessments and provide informed consent. Enrolled consumer participants will be asked to complete four assessment visits (baseline, week 4, week 8, and week 12) to collect comprehensive information about mental health, cultural connectedness and spirituality, social functioning, and experiences with and acceptability of OUD treatment. Providers at each clinical site will also be asked to complete surveys at three time points to assess attitudes, knowledge, and readiness related to MOUD.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Sequential
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Receiving services at a participating study site
  • Meet criteria for a current opioid use disorder
  • Identify as American Indian or Alaska Native
  • 18 years or older

排除标准

  • Not Applicable

结局指标

主要结局

# consumers with OUD initiated onto MOUD

时间窗: 6 months

number of consumers with OUD initiated onto MOUD in the 6 months after intervention delivery compared to pre-intervention

次要结局

  • # consumers with OUD retained in care for at least three months(6 months)
  • # consumers screened for OUD of the overall # of new consumers(6 months)
  • # consumers with OUD offered MOUD(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Aimee Campbell

Research Scientist

New York State Psychiatric Institute

研究点 (6)

Loading locations...

相似试验